Clinical Trials Sponsored by Life Science Pharmaceuticals

Total 1112 results

Verily Life Sciences LLC

Completed

Baseline Sleep Apnea Study #2

Obstructive Sleep Apnea of Adult

United States
Suven Life Sciences Limited

No longer available

Expanded Access to SUVN-G3031 (Samelisant) for the Treatment of Subjects With Narcolepsy

Narcolepsy
Wave Life Sciences Ltd.

Terminated

Safety and Tolerability of WVE-120102 in Patients With Huntington's Disease (PRECISION-HD2)

Huntington's Disease

United States, Denmark, Canada, Australia, United Kingdom, France, Germany, Poland
Tiziana Life Sciences LTD

Withdrawn

Phase 1b Multiple Ascending Dose Study of Foralumab in Primary and Secondary Progressive MS

Multiple Sclerosis | Primary Progressive Multiple Sclerosis | Secondary Progressive Multiple Sclerosis
Wave Life Sciences Ltd.

Terminated

Open-label Extension Study to Evaluate the Safety and Tolerability of WVE-120101 in Patients With Huntington's Disease

Huntington Disease

Denmark, Australia, Canada, France, United Kingdom, Germany, Poland
ReAlta Life Sciences, Inc.

Withdrawn

A Study of RLS-0071 in Patients With Acute Lung Injury Due to COVID-19 Pneumonia in Early Respiratory Failure

COVID-19 | Acute Lung Injury | ALI

United States
Banner Life Sciences LLC

Withdrawn

Observational Study in Patients With Relapsing-Remitting Multiple Sclerosis Switched to Bafiertam® From Dimethyl Fumarate (PERSIST)

Relapsing Remitting Multiple Sclerosis
Tiziana Life Sciences LTD

Completed

Study of Milciclib in Patients With Unresectable/Metastatic Hepatocellular Carcinoma

Hepatocellular Carcinoma

Israel, Greece, Italy
Wave Life Sciences Ltd.

Terminated

Efficacy and Safety Study of WVE-210201 (Suvodirsen) With Open-label Extension in Ambulatory Patients With Duchenne Muscular Dystrophy (DYSTANCE 51)

Duchenne Muscular Dystrophy

United States, Belgium, United Kingdom, Czechia, Canada, France, Italy, Sweden
Suven Life Sciences Limited

No longer available

Expanded Access to Provide SUVN-502 for the Treatment of Subjects With Alzheimer's Disease (SUVN-502)

Dementia | Alzheimer Disease | Cognition Disorders
Banner Life Sciences LLC

Completed

Study to Compare GI Tolerability Following Oral Administration of Bafiertam™ or Tecfidera to Healthy Volunteers

Multiple Sclerosis

United States
Sellas Life Sciences Group

Unknown

WT1 Analog Peptide Vaccine in Patients With Multiple Myeloma Following Autologous Stem Cell Transplantation

Multiple Myeloma | Minimal Residual Disease | High-Risk Cancer

United States
Sellas Life Sciences Group

Completed

WT-1 Analog Peptide Vaccine in Acute Myeloid Leukemia (AML) or Acute Lymphoblastic Leukemia (ALL)

Acute Myeloid Leukemia | Acute Lymphoblastic Leukemia

United States
CANbridge Life Sciences Ltd.

Completed

A Study of CAN008 for Newly Diagnosed Glioblastoma Multiforme

Glioblastoma Multiforme

Taiwan
Suven Life Sciences Limited

Completed

Effect of Food, Gender, and Age on the Pharmacokinetic Profile of SUVN-911 in Healthy Subjects (SUVN-911)

Major Depressive Disorder

United States
Sprim Advanced Life Sciences

Completed

Immune Response to the Consumption of Lactobacillus GG and FOS in Patients With Recurrent Herpes Labialis (EVIM)

Herpes Labialis
CANbridge Life Sciences Ltd.

Unknown

CAN008 Biomarker CD95 Ligand and CpG2 Methylation in Chinese Patients With Glioblastoma

Glioblastoma
Bioniche Life Sciences Inc.

Terminated

Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of Subjects With BCG Recurrent/Refractory Non-muscle Invasive Bladder Cancer (EMBARC-RF)

Carcinoma in Situ | Neoplasm Recurrence, Local | Bladder Neoplasm | Mycobacterium | Transitional Cell, Carcinoma

United States, Canada, Poland, Germany, Netherlands, United Kingdom
Suven Life Sciences Limited

Completed

A Study to Investigate the Safety, Tolerability and Pharmacokinetics of SUVN-G3031 in Healthy Subjects

Cognitive Disorders

United States
Bioniche Life Sciences Inc.

Withdrawn

First Line Comparative Study of EN3348 (MCC) vs BCG in NMIBC

Bladder Cancer

United States
Alltech Life Sciences Inc.

Completed

Safety and Tolerability of Antioxidant (AT-001)for Reducing Brain Oxidative Stress

Oxidative Stress

United States
Afexa Life Sciences Inc

Terminated

GLU-xx Formulations in Individuals With Impaired Glucose Tolerance

Impaired Glucose Tolerance

United States
Afexa Life Sciences Inc

Withdrawn

Phase 1B- Open Label Dose-Ranging Study of Oral AFX-2 in Adults With Chronic Lymphocytic Leukemia

Leukemia, Lymphocytic, Chronic, B-Cell

United States
Sprim Advanced Life Sciences

Terminated

Trenev Trio/Healthy Trinity for Symptoms of Diarrhea-predominant Irritable Bowel Syndrome (IBS) and Functional Dyspepsia

IBS-D and Functional Dyspepsia

United States
Afexa Life Sciences Inc

Completed

A Randomized, Double-blind, Placebo-controlled Study on the Effect of CVT-E002 in Patients With Seasonal Allergic Rhinitis

Seasonal Allergic Rhinitis

Canada
Advanced Life Sciences, Inc.

Completed

Study Comparing the Safety and Efficacy of Cethromycin to Clarithromycin for the Treatment of Community-Acquired Pneumonia

Pneumonia

United States
Advanced Life Sciences, Inc.

Unknown

Safety, Tolerability, and Preliminary Efficacy Study of ALS-357 in Patients With Cutaneous Metastatic Melanoma

Melanoma

United States
Clinical Life Sciences Ltd.

Completed

Effect of Plant Stanol Esters on Blood Lipids

Elevated Blood Lipids

Finland
ReAlta Life Sciences, Inc.

Not yet recruiting

Safety, PK, PD, Dosing, and Efficacy of RLS-0071for the Treatment of Hospitalized Patients With Steroid-Refractory Acute Graft-versus-Host Disease (AURORA)

Steroid Refractory GVHD
Power Life Sciences Inc.

Not yet recruiting

Examining Engagement Trends Among Participants in Peripheral Neuropathy Clinical Research

Peripheral Neuropathy

United States
Power Life Sciences Inc.

Not yet recruiting

Assessing Patient Engagement in Keratoconus Clinical Research

Keratoconus

United States
Power Life Sciences Inc.

Not yet recruiting

Delving Into Participation Trends of Scleroderma Clinical Trials

Scleroderma

United States
Power Life Sciences Inc.

Not yet recruiting

Studying Patterns in Patient Engagement Among Tardive Dyskinesia Patients

Tardive Dyskinesia

United States
Power Life Sciences Inc.

Not yet recruiting

Exploring Clinical Study Experiences of People With Anorexia Nervosa

Anorexia Nervosa

United States
Power Life Sciences Inc.

Not yet recruiting

Revealing Engagement Patterns Among Hepatic Encephalopathy Patients

Hepatic Encephalopathy

United States
Power Life Sciences Inc.

Not yet recruiting

Evaluating the Occurrence of Participation Trends Among Weight Loss Clinical Trials Patients

Weight Loss

United States
Power Life Sciences Inc.

Not yet recruiting

Determining Patterns In Trial Experiences of Recurrent Prostate Cancer Patients

Recurrent Prostate Cancer

United States
Power Life Sciences Inc.

Not yet recruiting

Insights Into Participating in Studies for Bone Cancer

Bone Cancer

United States
Power Life Sciences Inc.

Not yet recruiting

Investigating Participation Patterns Among Recurrent Ovarian Cancer Patients

Recurrent Ovarian Cancer

United States
Power Life Sciences Inc.

Not yet recruiting

Investigating Engagement Patterns and Participation Trends Among Liposarcoma Patients

Liposarcoma

United States
Power Life Sciences Inc.

Not yet recruiting

Understanding Engagement Trends in Chondrosarcoma Clinical Trials

Chondrosarcoma

United States
Power Life Sciences Inc.

Not yet recruiting

Delving Into Participation Patterns in Social Anxiety Studies

Social Anxiety

United States
Power Life Sciences Inc.

Not yet recruiting

Revealing Engagement Patterns Among Endometrial Cancer Patients

Endometrial Cancer

United States
Power Life Sciences Inc.

Not yet recruiting

Insights Into Participating in Studies for Uterine Cancer

Uterine Cancer

United States
Power Life Sciences Inc.

Not yet recruiting

Delving Into Borderline Personality Disorder Clinical Trial Experiences

Borderline Personality Disorder

United States
Power Life Sciences Inc.

Not yet recruiting

Evaluation of Study Experiences of Neuroendocrine Tumor Patients

Neuroendocrine Tumors

United States
Power Life Sciences Inc.

Not yet recruiting

Navigating the Clinical Research Process for Glioma

Glioma

United States
Power Life Sciences Inc.

Not yet recruiting

Evaluating Factors In Study Experiences of Lymphedema Patients

Lymphedema

United States
Power Life Sciences Inc.

Not yet recruiting

Assessment of Schizophrenia Patients' Clinical Study Experiences

Schizophrenia

United States
Power Life Sciences Inc.

Not yet recruiting

Studying Patient Experiences in Osteoporosis Clinical Trials

Osteoporosis

United States

Clinical Trials Sponsored by Life Science Pharmaceuticals

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in New Zealand

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations